AGO-OVAR 2.29
Trial Description:
Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer
Lead Cooperative Group:
Trial Number:
Disease Site:
Recurrent Ovarian
Trial Status:
Follow Up
Contact person:
pharter